Adaptive Biotechnologies Corp vs Comcast Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.05B), while Comcast Corporation trades at $25.63 (market cap $89.43B). The key difference: Comcast Corporation is far larger — about 22.1× Adaptive Biotechnologies Corp's market cap, and Comcast Corporation pays a 5.24% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | CMCSA | |
|---|---|---|
Market Cap | $4.05B | $89.43B |
Sector | Health | Media |
52-Week High | $25.45 | $32.50 |
52-Week Low | $12.30 | $21.92 |
Enterprise Value | $4.12B | $172.15B |
Dividend Yield | — | 5.24% |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to roughly 61 million U.S. homes and businesses, or nearly half of the country. About 56% of the homes in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC broadcast network, several local NBC affiliates, Universal Studios, and several theme parks. Sky, acquired in 2018, is the dominant television provider in the U.K. and has invested heavily in exclusive and proprietary content to build this position. The firm is also the largest pay-television provider in Italy and has a presence in Germany and Austria.
Read more on CMCSA →